What you need to know about the drugs being used for weight loss

Global sales of anti-obesity medications are forecast to be worth nearly NZ$50 billion by the end of this decade. (Image: Depositphotos)

Bloomberg

Sun, 23 Apr 2023

By Emma Court and Suzi Ring Obesity is among the world’s most common health conditions, but for years medicine has had few effective approaches to offer, short of surgery. That’s why there’s been so much excitement about a new class of drugs that’s helping patients shed dozens of kilos at far lower risk. Supplies can barely keep up with demand, and researchers are racing to come up with more. Yet there are big hurdles that could keep the medications from many or most of the billion or so people worldw...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Already a Subscriber ? Sign in here.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Economy

Jones looking at gas rationing

“The wholesale hollowing out of the regional manufacturing sector.”

Ian Llewellyn 2:40pm

Markets

Metroglass recap plan hands control to Amari Metals

An independent report said Metroglass was left with “no viable alternatives”.

Gregor Thompson 1:30pm

Metroglass recap plan hands control to Amari Metals

Opinion

Cameron Bagrie: Treasury signals need for independent fiscal watchdog

Cameron Bagrie 10:00am

Sponsored

Why NZ businesses lag on solar and the adoption of clean on-site renewable energy

Aussie firms are beating Kiwis in solar use – but that can change.

Lightforce

Sponsored

A decade in, Spark’s AI journey is paying off

The telco’s use of AI offers insights for every Kiwi business.

Spark

More Health

Markets

Radius Care upgrades earnings guidance

Radius Residential Care has upgraded its earnings outlook ahead of its annual shareholders’ meeting on Thursday.The listed aged-care specialist said it now expects underlying earnings before interest, taxes, depreciation and amortisation (Ebitda) for the six months to October to...

Staff reporters 07 Aug 2025